Peptide Sciences Shut Down: What Researchers Need to Know in 2026

In March 2026, Peptide Sciences — for years one of the most recognized names in the US research peptide market — ceased operations. For a large segment of the research community that had come to rely on them as a primary supplier, this closure came as a significant disruption. Finding a replacement that meets the same quality expectations is not a trivial task, and the research community deserves a straightforward, factual breakdown of what happened and what legitimate options remain.

This post is written for qualified researchers who are actively looking for a Peptide Sciences alternative in 2026. We’ll cover what led to the shutdown, what criteria should guide your evaluation of any new supplier, and which vendors — including Cre8tive Labs — are currently operating with transparent, verifiable quality standards.

What Happened to Peptide Sciences?

Peptide Sciences’ closure was not sudden. Over the course of 2025 and into early 2026, the supplier accumulated 37 documented batch failures — a pattern that drew sustained criticism across research communities on forums and review platforms. These failures spanned multiple compound classes and raised questions not just about individual lots, but about the underlying quality assurance infrastructure.

By March 2026, operations had ceased entirely. The website went dark, outstanding orders went unfulfilled, and a community that had placed meaningful trust in the brand was left without a primary source.

It is worth stating plainly: batch failures at this scale are not a minor quality control issue. In research contexts, compromised purity or misidentified compounds can invalidate months of work. The research community’s frustration is legitimate. Equally legitimate is the search for suppliers who take third-party verification seriously.

What Researchers Should Look for in a Replacement Supplier

Not all peptide suppliers operate to the same standard. When evaluating a Peptide Sciences replacement in 2026, these are the criteria that matter most for research-grade procurement:

• Third-party COA (Certificate of Analysis): Every batch should be tested by an independent laboratory — not an in-house team. The lab name, report date, and batch number should all be visible.
• HPLC purity data: High-Performance Liquid Chromatography is the standard method for measuring peptide purity. Look for ≥98% purity thresholds and demand that the number is present in the COA, not implied.
• Identity confirmation testing: Purity alone is insufficient. Mass spectrometry or equivalent identity testing should confirm that the compound is what it claims to be — not merely that the sample is “pure.”
• Public verification: The most trustworthy COA systems allow researchers to verify results independently, often via QR code linked to the lab’s own public database. This removes the possibility of fabricated documentation.
• Domestic vs. international sourcing: US-based suppliers reduce shipping risk, customs complications, and cold-chain concerns. For researchers operating on timelines, this is a practical consideration, not just a preference.
• Compound breadth: A supplier offering a narrow catalog forces researchers to maintain multiple vendor relationships. A verified supplier covering a wide range of compound classes reduces that fragmentation.

Why Janoshik-Tested Supply Matters

Among third-party testing laboratories, Janoshik (based in the Czech Republic) has emerged as a widely respected standard in the research peptide community. Their reputation is built on two factors: methodological rigor and public transparency.

Janoshik performs both HPLC purity analysis and compound identity testing across a multi-compound panel. Their results are published to a public database at public.janoshik.com, where any researcher can independently verify a COA using a batch-specific QR code. This is not a vendor-hosted verification portal — it is the lab’s own system, with no vendor intermediary.

What does this mean practically? When a supplier publishes a Janoshik COA with a public QR code, the researcher can scan that code and confirm the results are real, unaltered, and tied to the specific batch in question. This is the current gold standard for COA transparency in the US research market.

A 13-compound Janoshik panel — testing identity and purity across a broad set of compounds simultaneously — provides a level of assurance that single-compound or in-house testing simply cannot match. When evaluating any Peptide Sciences alternative, whether that is Cre8tive Labs or any other supplier, this type of multi-compound independent verification should be a baseline expectation, not a premium feature.

Cre8tive Labs: A Verified Alternative for Qualified Researchers

Cre8tive Labs (cre8tivelabs.com) is a US-based supplier of research-grade peptides, operating under an in-vitro research use only model. All products are sold exclusively to qualified researchers and are not intended for human consumption.

Their testing standard is 13-compound Janoshik panel testing, with ≥98% HPLC purity verification on every batch. COAs are published in a public library at cre8tivelabs.com/coa/, each accompanied by a QR code that links directly to the corresponding Janoshik public record.

Current catalog includes: BPC-157, TB-500, GHK-Cu (offered as GLOW Blend), GLP-1 research compounds (cataloged as CL-1, CL-2, and CL-3), AOD-9604, PT-141, MOTS-c, SS-31, CJC-1295 / Ipamorelin, Sermorelin, and Tesamorelin.

COA documentation for each compound is available before purchase, allowing researchers to review batch-specific data prior to procurement decisions.

Other Verified Sources Worth Considering

Cre8tive Labs is one option, but not the only legitimate one. For displaced Peptide Sciences customers, the research community has also recognized the following suppliers as operating to a high standard:

• Fifty410: Widely regarded within the community as a gold-standard domestic supplier. Strong reputation for consistency and third-party documentation.
• Ascension Peptides: Known for triple-lab testing protocols, providing an additional layer of verification across multiple independent sources.

Any of these suppliers represents a meaningfully different standard from what contributed to Peptide Sciences’ closure. The common thread is third-party verification that researchers can independently confirm — not vendor assertions without supporting documentation.

Next Steps for Displaced Researchers

If you are currently sourcing compounds previously obtained through Peptide Sciences, the most important immediate step is not simply finding the fastest available replacement — it is finding a replacement whose documentation you can verify independently.

Review the COA library at cre8tivelabs.com/coa/ to evaluate batch-level testing data before making a procurement decision. The full compound catalog is available at cre8tivelabs.com/shop/.

---

All content on this page is for informational and educational purposes only. Cre8tive Labs products are sold for in-vitro research use only by qualified researchers. Not for human consumption.